1994
DOI: 10.1177/009286159402800140
|View full text |Cite
|
Sign up to set email alerts
|

Completeness of Adverse Drug Experience Reporting to the FDA: II. A Comparison of Manufacturer and Direct Reports on New Molecular Entities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 1 publication
0
0
0
Order By: Relevance